A comparative assessment of prostate positioning guided by three-dimensional ultrasound and cone beam CT - Abstract

BACKGROUND: The accuracy of the Elekta ClarityTM three-dimensional ultrasound system (3DUS) was assessed for prostate positioning and compared to seed- and bone-based positioning in kilo-voltage cone-beam computed tomography (CBCT) during a definitive radiotherapy.

METHODS: The prostate positioning of 6 patients, with fiducial markers implanted into the prostate, was controlled by 3DUS and CBCT. In total, 78 ultrasound scans were performed trans-abdominally and compared to bone-matches and seed-matches in CBCT scans. Setup errors detected by the different modalities were compared. Systematic and random errors were analysed, and optimal setup margins were calculated.

RESULTS: The discrepancy between 3DUS and seed-match in CBCT was -0.2 ± 2.7 mm laterally, -1.9 ± 2.3 mm longitudinally and 0.0 ± 3.0 mm vertically and significant only in longitudinal direction. Using seed-match as reference, systematic errors of 3DUS were 1.3 mm laterally, 0.8 mm longitudinally and 1.4 mm vertically, and random errors were 2.5 mm laterally, 2.3 mm longitudinally, and 2.7 mm vertically. No significant difference could be detected for 3DUS in comparison to bone-match in CBCT.

CONCLUSIONS: 3DUS is feasible for image guidance for patients with prostate cancer and appears comparable to CBCT based image guidance in the retrospective study. While 3DUS offers some distinct advantages such as no need of invasive fiducial implantation and avoidance of extra radiation, its disadvantages include the operator dependence of the technique and dependence on sufficient bladder filling. Further study of 3DUS for image guidance in a large patient cohort is warranted.

Written by:
Li M, Ballhausen H, Hegemann NS, Ganswindt U, Manapov F, Tritschler S, Roosen A, Gratzke C, Reiner M, Belka C.   Are you the author?
Department of Radiation Oncology, University Hospital Munich, Ludwig-Maximilians-University, Munich, Germany; Department of Urology, University Hospital Munich, Ludwig-Maximilians-University, Munich, Germany.  ; ; ; ; ; ; ; ; ;

Reference: Radiat Oncol. 2015 Apr 9;10(1):82.
doi: 10.1186/s13014-015-0380-1


PubMed Abstract
PMID: 25890013

UroToday.com Prostate Cancer Section